多肽CRDMO平台
目录肽
中肽生化目录肽版块全新呈现，致力于打造全球最全面的多肽供应平台！我们专业的学术团队将时刻追踪最新最热的研究动向，帮助您发现实际需求，并以最高质量标准提供您所需要的产品。我们将我们将不定期更新产品列表，为您最大限度地节约科研时间，敬请广大客户朋友关注！
SUBP-003B
Spantide II
DLys(Nicotinoyl)-Pro-(3-Pyridyl)Ala-Pro-(3,4-dichloro)DPhe-Asn-DTrp-Phe-DTrp-Leu-Nle-NH2
DLys(Nicotinoyl)-Pro-(3-Pyridyl)Ala-Pro-(3,4-dichloro)DPhe-Asn-DTrp-Phe-DTrp-Leu-Nle-NH2
Size：1.0
P1(RMB)：490
MW：1670.8
One letter sequence：DLys(Nicotinoyl)-P-(3-Pyridyl)Ala-P-(3,4-dichloro)DPhe-N-DTrp-F-DTrp-L-Nle-NH2
Molecular Formula：C86H106N18O13Cl2
Description：Tachykinin antagonist that is a more potent substance P antagonist than spantide I and less effective in releasing histamine from mast cells. It also displays negligible neurotoxicity when compared with spantide I.
Literature Reference：Folkers et al., PNAS, 87, 4833 (1990); \nR. Kakanson et al., BBRC, 178, 297 (1991)
Cas：
P1(RMB)：490
MW：1670.8
One letter sequence：DLys(Nicotinoyl)-P-(3-Pyridyl)Ala-P-(3,4-dichloro)DPhe-N-DTrp-F-DTrp-L-Nle-NH2
Molecular Formula：C86H106N18O13Cl2
Description：Tachykinin antagonist that is a more potent substance P antagonist than spantide I and less effective in releasing histamine from mast cells. It also displays negligible neurotoxicity when compared with spantide I.
Literature Reference：Folkers et al., PNAS, 87, 4833 (1990); \nR. Kakanson et al., BBRC, 178, 297 (1991)
Cas：
